Assenagon Asset Management
IMGN

Assenagon Asset Management’s Immunogen Inc IMGN Stock Holding History

Assenagon Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,987,334
Closed -$18M – 1304
2020
Q3 		$18M Buy
4,987,334
+4,811,013
+2,729% +$19.4M 0.1% 135
2020
Q2 		$811K Buy
+176,321
New +$750K 0.01% 881
2019
Q3 		– Sell
-118,316
Closed -$257K – 1117
2019
Q2 		$257K Buy
+118,316
New +$280K ﹤0.01% 931
2018
Q4 		– Sell
-61,112
Closed -$579K – 1189
2018
Q3 		$579K Buy
+61,112
New +$587K 0.01% 694

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Assenagon Asset Management's IMGN Position: Q4 2020 in Review

Assenagon Asset Management sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 4,987,334 shares — an estimated $18M sold.

Assenagon Asset Management first reported a position in IMGN in Q3 2018 and held it in 4 quarters. The position peaked at $18M in Q3 2020. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

  • Assenagon Asset Management reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 4,987,334 Immunogen Inc shares in Q4 2020, an estimated $18M.
  • Assenagon Asset Management first reported a position in Immunogen Inc in Q3 2018 and held it in 4 quarters.
  • Assenagon Asset Management's Immunogen Inc position peaked at $18M in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on Assenagon Asset Management's 13F filing for Q4 2020, filed 1 Feb 2021.